Literature DB >> 9078226

Third-generation oral contraceptives and venous thrombosis.

H Jick, S S Jick, M W Myers, C Vasilakis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078226     DOI: 10.1016/S0140-6736(05)60173-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Benefits and risks of third-generation oral contraceptives.

Authors:  E S Leblanc; A Laws
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

Review 2.  Cardiovascular events associated with different combined oral contraceptives: a review of current data.

Authors:  P Hannaford
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

3.  Validation of the diagnosis of venous thromboembolism in general practice database studies.

Authors:  R Lawrenson; J C Todd; G M Leydon; T J Williams; R D Farmer
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

4.  A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; J C Todd; T J Williams; K D MacRae; F Tyrer; G M Leydon
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

5.  Antihypertensive medication use and incident breast cancer in women.

Authors:  Elizabeth E Devore; Sung Kim; Cody A Ramin; Lani R Wegrzyn; Jennifer Massa; Michelle D Holmes; Karin B Michels; Rulla M Tamimi; John P Forman; Eva S Schernhammer
Journal:  Breast Cancer Res Treat       Date:  2015-02-21       Impact factor: 4.872

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 7.  Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis.

Authors:  Farnaz Amoozegar; Paul E Ronksley; Reg Sauve; Bijoy K Menon
Journal:  Front Neurol       Date:  2015-02-02       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.